OFFICIAL-SOURCE RECALL · AUSTRALIA
Pertuzumab 420mg in 0.9% Sodium Chloride in Polyolefin Bag Recall: Classification Class II Reason for the
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Pertuzumab 420mg in 0.9% Sodium Chloride in Polyolefin Bag (Freeflex) for Intravenous Infusion
- Manufacturer
- See official notice
- Lot number
- BB26084718
- Batch number
- BB26084718
- Date code
- dates, Date
- Expiration date
- dates, Date
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Classification Class II Reason for the Action Cairns Hospital reported on 11/08/2026 that a Pertuzumab infusion bag (BB26084718) had expired prior to treatment. The single dose unit had expired during transit to the customer. The customer advised the single dose unit was not administrated and discarded. A replacement unit was provided to the customer. This recall does not affect any other compounded batches of Pertuzumab or any other Slade Health products. Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). Instructions for Customers/Users - The product has been discarded by the customer. - A replacement product has been provided to the customer. Action Commencement Date 17/08/2026 Responsible Entity Slade Health Pty Ltd
Hazard
Classification Class II Reason for the Action Cairns Hospital reported on 11/08/2026 that a Pertuzumab infusion bag (BB26084718) had expired prior to treatment. The single dose unit had expired during transit to the customer. The customer advised the single dose unit was not administrated and discarded. A replacement unit was provided to the customer. This recall does not affect any other compounded batches of Pertuzumab or any other Slade Health products. Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). Instructions for Customers/Users - The product has been discarded by the customer. - A replacement product has been provided to the customer. Action Commencement Date 17/08/2026 Responsible Entity Slade Health Pty Ltd
Official recall notice
Pertuzumab 420mg in 0.9% Sodium Chloride in Polyolefin Bag (Freeflex) for Intravenous Infusion
Agency: Therapeutic Goods Administration
Official publication date: August 7, 2026
Read the official AU_TGA_DRAC recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
